NeuroMetrix Market Capitalization vs Price to Sales Ratio Analysis

NURO Stock

USD 4.33 0.68 18.63%

NeuroMetrix financial indicator trend analysis is infinitely more than just investigating NeuroMetrix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroMetrix is a good investment. Please check the relationship between NeuroMetrix Market Cap and its Price To Sales Ratio accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

Market Cap vs Price To Sales Ratio

Market Capitalization vs Price to Sales Ratio Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroMetrix Market Capitalization account and Price to Sales Ratio. At this time, the significance of the direction appears to have fragmental relationship.

The correlation between NeuroMetrix's Market Capitalization and Price to Sales Ratio is 0.58. Overlapping area represents the amount of variation of Market Capitalization that can explain the historical movement of Price to Sales Ratio in the same time period over historical financial statements of NeuroMetrix, assuming nothing else is changed. The correlation between historical values of NeuroMetrix's Market Capitalization and Price to Sales Ratio is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Market Capitalization of NeuroMetrix are associated (or correlated) with its Price to Sales Ratio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Price to Sales Ratio has no effect on the direction of Market Capitalization i.e., NeuroMetrix's Market Capitalization and Price to Sales Ratio go up and down completely randomly.

Correlation Coefficient

0.58

Relationship Direction	Positive
Relationship Strength	Weak

View All Relationships

Market Cap

Price To Sales Ratio

Price to Sales Ratio is figured by comparing NeuroMetrix stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on NeuroMetrix sales, a figure that is much harder to manipulate than other NeuroMetrix multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company’s stock price to its revenues, calculated by dividing the company’s market cap by its total sales or revenue over a 12-month period.

Most indicators from NeuroMetrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroMetrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.As of the 19th of April 2024, Selling General Administrative is likely to drop to about 4.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 2.5 M

	2021	2022	2023	2024 (projected)
Gross Profit	5.9M	5.8M	3.9M	3.8M
Total Revenue	8.3M	8.3M	5.9M	5.6M

Gross Profit Total Revenue

NeuroMetrix fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Preferred Stock Total Equity
Common Stock Shares Outstanding		0.57	-0.09	-0.01	0.04	0.43	-0.31	0.03	0.15	0.17	-0.61	0.07	-0.16	-0.25	-0.26	0.1	0.47	0.02	0.31	-0.26	0.69	0.16	0.58	-0.26	0.4	-0.22
Total Assets	0.57		-0.32	-0.43	-0.42	0.7	-0.15	-0.08	-0.35	-0.37	-0.45	-0.17	0.38	-0.34	-0.3	0.12	0.98	-0.24	0.08	-0.32	0.15	-0.16	0.53	-0.38	0.69	-0.3
Short Long Term Debt Total	-0.09	-0.32		0.55	0.63	0.09	0.34	0.18	0.38	0.02	-0.33	0.66	-0.02	-0.25	-0.38	-0.61	-0.32	0.15	0.46	-0.35	0.05	0.67	0.28	-0.28	-0.14	-0.39
Other Current Liab	-0.01	-0.43	0.55		0.87	0.07	0.06	0.08	0.6	0.14	-0.26	0.7	-0.15	-0.31	-0.38	-0.67	-0.51	0.55	0.3	-0.42	0.45	0.61	0.23	-0.32	-0.33	-0.42
Total Current Liabilities	0.04	-0.42	0.63	0.87		-0.02	-0.04	0.09	0.81	0.02	-0.16	0.89	-0.03	-0.17	-0.24	-0.58	-0.49	0.67	0.25	-0.3	0.56	0.79	0.12	-0.19	-0.3	-0.3
Total Stockholder Equity	0.43	0.7	0.09	0.07	-0.02		-0.11	0.13	-0.25	-0.32	-0.81	0.11	0.33	-0.76	-0.88	-0.54	0.71	-0.31	0.29	-0.9	0.19	0.18	0.89	-0.93	0.48	-0.88
Other Liab	-0.31	-0.15	0.34	0.06	-0.04	-0.11		-0.35	-0.06	-0.16	0.2	-0.04	0.15	-0.27	-0.09	-0.25	-0.06	-0.15	0.52	0.07	-0.4	-0.12	-0.18	0.07	-0.31	-0.05
Property Plant And Equipment Net	0.03	-0.08	0.18	0.08	0.09	0.13	-0.35		-0.38	0.14	-0.41	0.11	-0.1	0.37	-0.19	-0.04	-0.09	-0.32	-0.36	-0.22	0.02	0.02	0.35	-0.21	0.52	-0.2
Current Deferred Revenue	0.15	-0.35	0.38	0.6	0.81	-0.25	-0.06	-0.38		0.04	0.15	0.73	-0.06	-0.11	0.1	-0.27	-0.43	0.81	0.32	0.04	0.6	0.66	-0.18	0.14	-0.46	0.06
Net Debt	0.17	-0.37	0.02	0.14	0.02	-0.32	-0.16	0.14	0.04		-0.05	-0.11	-1.0	0.24	0.19	0.17	-0.46	0.21	-0.1	0.2	0.31	0.05	-0.04	0.2	-0.26	0.21
Retained Earnings	-0.61	-0.45	-0.33	-0.26	-0.16	-0.81	0.2	-0.41	0.15	-0.05		-0.16	0.03	0.56	0.82	0.45	-0.4	0.27	-0.31	0.81	-0.33	-0.39	-0.99	0.82	-0.49	0.8
Accounts Payable	0.07	-0.17	0.66	0.7	0.89	0.11	-0.04	0.11	0.73	-0.11	-0.16		0.1	-0.15	-0.24	-0.56	-0.24	0.65	0.31	-0.32	0.55	0.72	0.15	-0.22	-0.11	-0.32
Cash	-0.16	0.38	-0.02	-0.15	-0.03	0.33	0.15	-0.1	-0.06	-1.0	0.03	0.1		-0.23	-0.2	-0.16	0.46	-0.24	0.08	-0.21	-0.32	-0.05	0.06	-0.22	0.29	-0.22
Non Current Assets Total	-0.25	-0.34	-0.25	-0.31	-0.17	-0.76	-0.27	0.37	-0.11	0.24	0.56	-0.15	-0.23		0.84	0.73	-0.37	0.1	-0.6	0.8	-0.13	-0.32	-0.64	0.8	0.08	0.82
Non Currrent Assets Other	-0.26	-0.3	-0.38	-0.38	-0.24	-0.88	-0.09	-0.19	0.1	0.19	0.82	-0.24	-0.2	0.84		0.81	-0.33	0.29	-0.41	0.98	-0.15	-0.36	-0.87	0.98	-0.21	0.99
Other Assets	0.1	0.12	-0.61	-0.67	-0.58	-0.54	-0.25	-0.04	-0.27	0.17	0.45	-0.56	-0.16	0.73	0.81		0.09	-0.07	-0.42	0.8	-0.14	-0.51	-0.5	0.76	0.13	0.83
Cash And Short Term Investments	0.47	0.98	-0.32	-0.51	-0.49	0.71	-0.06	-0.09	-0.43	-0.46	-0.4	-0.24	0.46	-0.37	-0.33	0.09		-0.37	0.07	-0.32	0.0	-0.23	0.49	-0.4	0.66	-0.32
Net Receivables	0.02	-0.24	0.15	0.55	0.67	-0.31	-0.15	-0.32	0.81	0.21	0.27	0.65	-0.24	0.1	0.29	-0.07	-0.37		0.03	0.18	0.61	0.52	-0.29	0.27	-0.38	0.21
Common Stock Total Equity	0.31	0.08	0.46	0.3	0.25	0.29	0.52	-0.36	0.32	-0.1	-0.31	0.31	0.08	-0.6	-0.41	-0.42	0.07	0.03		-0.36	0.25	0.22	0.33	-0.34	-0.23	-0.42
Non Current Liabilities Total	-0.26	-0.32	-0.35	-0.42	-0.3	-0.9	0.07	-0.22	0.04	0.2	0.81	-0.32	-0.21	0.8	0.98	0.8	-0.32	0.18	-0.36		-0.24	-0.39	-0.87	0.99	-0.22	0.99
Inventory	0.69	0.15	0.05	0.45	0.56	0.19	-0.4	0.02	0.6	0.31	-0.33	0.55	-0.32	-0.13	-0.15	-0.14	0.0	0.61	0.25	-0.24		0.42	0.31	-0.18	0.01	-0.19
Other Current Assets	0.16	-0.16	0.67	0.61	0.79	0.18	-0.12	0.02	0.66	0.05	-0.39	0.72	-0.05	-0.32	-0.36	-0.51	-0.23	0.52	0.22	-0.39	0.42		0.35	-0.31	-0.12	-0.38
Other Stockholder Equity	0.58	0.53	0.28	0.23	0.12	0.89	-0.18	0.35	-0.18	-0.04	-0.99	0.15	0.06	-0.64	-0.87	-0.5	0.49	-0.29	0.33	-0.87	0.31	0.35		-0.88	0.49	-0.85
Total Liab	-0.26	-0.38	-0.28	-0.32	-0.19	-0.93	0.07	-0.21	0.14	0.2	0.82	-0.22	-0.22	0.8	0.98	0.76	-0.4	0.27	-0.34	0.99	-0.18	-0.31	-0.88		-0.26	0.99
Property Plant And Equipment Gross	0.4	0.69	-0.14	-0.33	-0.3	0.48	-0.31	0.52	-0.46	-0.26	-0.49	-0.11	0.29	0.08	-0.21	0.13	0.66	-0.38	-0.23	-0.22	0.01	-0.12	0.49	-0.26		-0.19
Preferred Stock Total Equity	-0.22	-0.3	-0.39	-0.42	-0.3	-0.88	-0.05	-0.2	0.06	0.21	0.8	-0.32	-0.22	0.82	0.99	0.83	-0.32	0.21	-0.42	0.99	-0.19	-0.38	-0.85	0.99	-0.19

Click cells to compare fundamentals

NeuroMetrix Account Relationship Matchups

NeuroMetrix fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	121.0K	376.8K	638.9K	891.3K	1.0M	1.1M
Total Assets	6.9M	8.0M	24.9M	24.7M	21.4M	17.5M
Other Current Liab	2.1M	1.5M	853.2K	589.9K	1.2M	1.9M
Total Current Liabilities	3.4M	2.3M	1.4M	1.1M	1.2M	1.2M
Total Stockholder Equity	2.5M	5.2M	23.2M	23.4M	20.1M	14.4M
Property Plant And Equipment Net	1.4M	876.2K	673.9K	536.2K	543.6K	599.7K
Net Debt	(2.2M)	(4.8M)	(22.3M)	(3.9M)	(1.5M)	(1.6M)
Retained Earnings	(194.8M)	(196.9M)	(199.2M)	(203.6M)	(210.1M)	(220.6M)
Accounts Payable	725.7K	142.3K	284.0K	368.1K	215.5K	204.7K
Cash	3.1M	5.2M	22.6M	4.3M	1.7M	1.6M
Non Current Assets Total	1.5M	904.7K	700.3K	562.6K	570.0K	541.5K
Non Currrent Assets Other	74.9K	29.7K	28.5K	26.4K	30.4K	31.9K
Other Assets	30.3K	29.7K	721.2K	700.3K	630.3K	600.4K
Cash And Short Term Investments	3.1M	5.2M	22.6M	21.2M	18.0M	12.0M
Net Receivables	488.0K	334.3K	310.8K	646.8K	518.8K	492.9K
Common Stock Total Equity	271.0	738.0	140.0	379.0	341.1	669.34
Liabilities And Stockholders Equity	6.9M	8.0M	24.9M	24.7M	21.4M	17.5M
Non Current Liabilities Total	916.7K	461.4K	306.7K	207.5K	92.5K	87.9K
Inventory	1.2M	1.1M	706.6K	1.6M	1.6M	1.6M
Other Current Assets	2.3M	1.9M	1.6M	2.9M	779.0K	740.1K
Other Stockholder Equity	197.3M	202.1M	222.4M	226.9M	230.0M	241.5M
Total Liab	4.4M	2.7M	1.7M	1.3M	1.3M	1.3M
Property Plant And Equipment Gross	1.4M	183.5K	2.0M	1.2M	1.3M	926.1K
Total Current Assets	5.4M	7.1M	24.2M	24.1M	20.9M	15.7M
Accumulated Other Comprehensive Income	(1.1M)	(1.2M)	(1.2M)	240.2K	216.2K	227.0K
Common Stock	140.0	379.0	668.0	778.0	152.0	144.4
Property Plant Equipment	2.4M	273.4K	183.5K	673.9K	606.5K	621.0K
Retained Earnings Total Equity	(191.3M)	(191.0M)	(194.8M)	(196.9M)	(177.2M)	(186.1M)
Net Tangible Assets	6.1M	2.5M	5.2M	23.2M	26.7M	28.0M
Capital Surpluse	196.4M	197.1M	197.3M	202.1M	232.4M	201.3M
Net Invested Capital	2.5M	5.2M	23.2M	23.4M	20.1M	13.4M
Net Working Capital	2.0M	4.8M	22.8M	23.0M	19.6M	12.9M
Capital Stock	141.0	380.0	669.0	779.0	153.0	145.35

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether NeuroMetrix offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NeuroMetrix's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Neurometrix Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Neurometrix Stock:

How To Invest In NeuroMetrix

Details

Is NeuroMetrix Stock a good investment?

Details

What is NeuroMetrix's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.

To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Complementary Tools for NeuroMetrix Stock analysis

When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.

	Fundamental Analysis View fundamental data based on most recent published financial statements
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
	Economic Indicators Top statistical indicators that provide insights into how an economy is performing
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios
	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments

Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(6.27)

Revenue Per Share

5.664

Quarterly Revenue Growth

(0.29)

Return On Assets

(0.19)

Return On Equity

(0.30)

The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

NeuroMetrix Market Capitalization vs Price to Sales Ratio Analysis

Market Cap vs Price To Sales Ratio

Market Capitalization vs Price to Sales Ratio Correlation Analysis

Correlation Coefficient

Market Cap

Price To Sales Ratio

NeuroMetrix fundamental ratios Correlations

NeuroMetrix Account Relationship Matchups

High Positive Relationship

High Negative Relationship

NeuroMetrix fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for NeuroMetrix Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Preferred Stock Total Equity	+ 0.99	Non Currrent Assets Other
Total Liab	+ 0.99	Non Current Liabilities Total
Preferred Stock Total Equity	+ 0.99	Non Current Liabilities Total
Preferred Stock Total Equity	+ 0.99	Total Liab
Cash And Short Term Investments	+ 0.98	Total Assets
Non Current Liabilities Total	+ 0.98	Non Currrent Assets Other

Cash	- 1.0	Net Debt
Other Stockholder Equity	- 0.99	Retained Earnings
Total Liab	- 0.93	Total Stockholder Equity
Non Current Liabilities Total	- 0.9	Total Stockholder Equity
Total Liab	- 0.88	Other Stockholder Equity
Preferred Stock Total Equity	- 0.88	Total Stockholder Equity